Baloxavir

DRUG4 trials

Sponsors

Bassett Healthcare, Insight Therapeutics, LLC, University of Oxford, Unity Health Toronto

Conditions

Acute Respiratory Infections (ARIs)InfluenzaInfluenza -Like IllnessInfluenza AInfluenza BInfluenza, HumanSAR-CoV-2

Phase 2

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

Bassett HealthcareInfluenza

Start: 2020-04-03End: 2025-06-01Target: 60Updated: 2023-10-30

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

RecruitingNCT05648448

University of OxfordInfluenza, Influenza, Human

Start: 2023-02-22End: 2027-01-01Target: 3000Updated: 2026-02-19

Phase 3

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

Not yet recruitingNCT07314905

Unity Health TorontoAcute Respiratory Infections (ARIs), Influenza A, Influenza B +1

Start: 2026-01-02End: 2027-04-24Target: 264Updated: 2026-01-02

Phase 4

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Insight Therapeutics, LLCInfluenza, Influenza, Human, Influenza -Like Illness

Start: 2021-08-06End: 2023-12-31Target: 1000Updated: 2023-03-15

Related Papers

901. The Impact of Cost-Free On-Site Influenza Point of Care Antigen Testing on Influenza Detection in Nursing Homes

Open Forum Infectious Diseases2023-11-27